Merck KGaA to acquire Bio-Techne for $11.3 billion

June 25, 2026 6:10 AM

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne Corporation (NASDAQ: TECH) for $73 per share in cash, representing a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found